-
Asunercept (APG101) is a soluble CD95-Fc fusion protein targeting CD95L.
-
Olutasidenib is a highly potent, selective inhibitor of mutant IDH1 that could be used in the treatment of AML or myelodysplastic syndrome (MDS).
Categories
Others
Archives
- February 2023 (1)
- June 2019 (1)